Brief: Targovax Enters Collaboration With Leidos

Circio Holding ASA

04/06/2020 07:02

June 4 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX ENTERS COLLABORATION WITH LEIDOS TO ADD
CHECKPOINT
INHIBITOR FUNCTIONALITY TO ONCOS VIRUSES
    * UNDER AGREEMENT, LEIDOS AND TARGOVAX WILL INVESTIGATE
TECHNICAL
FEASIBILITY, IN VITRO AND IN VIVO IMMUNE MODULATORY, AND
ANTI-CANCER PROPERTIES OF ENCODING MICROTIDE™ CHECKPOINT
PEPTIDES IN ONCOS ADENOVIRUS BACKBONE
    * IF SUCCESSFUL, COMBINED ONCOS AND MICROTIDE™ CONSTRUCTS
MAY
SERVE AS A PLATFORM WHERE ADDITIONAL FUNCTIONALITY CAN BE BUILT
IN TO STIMULATE MULTIPLE COMPLEMENTARY ANTI-TUMOR MECHANISMS

Source text for Eikon:  ID:nWkr8xVgcD 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))